Clinical Trial Update: Anti-ST2 (MSTT1041A) in COPD (COPD-ST2OP) [Phase 2]

View source ↗

Summary

Phase 2 trial update for anti-ST2 (MSTT1041A) in COPD with a completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Anti-ST2 (MSTT1041A) (MSTT1041A)

Snippet

Sponsor: University of Leicester | Conditions: COPD Exacerbation | Phase 2 | Status: COMPLETED | Results posted: 2022-05-24